PharmaTher Holdings Ltd. (CSE: PHRM)
Canada
· Delayed Price · Currency is CAD
0.220
+0.010 (4.76%)
Nov 22, 2024, 1:41 PM EST
PharmaTher Holdings Statistics
Total Valuation
PharmaTher Holdings has a market cap or net worth of CAD 21.69 million. The enterprise value is 19.79 million.
Market Cap | 21.69M |
Enterprise Value | 19.79M |
Important Dates
The last earnings date was Tuesday, November 5, 2024.
Earnings Date | Nov 5, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
PharmaTher Holdings has 88.52 million shares outstanding. The number of shares has increased by 0.16% in one year.
Current Share Class | n/a |
Shares Outstanding | 88.52M |
Shares Change (YoY) | +0.16% |
Shares Change (QoQ) | +0.14% |
Owned by Insiders (%) | 18.62% |
Owned by Institutions (%) | 0.06% |
Float | 72.02M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 11.08 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -9.15 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.98
Current Ratio | 7.98 |
Quick Ratio | 7.95 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -71.59% and return on invested capital (ROIC) is -41.80%.
Return on Equity (ROE) | -71.59% |
Return on Assets (ROA) | -35.61% |
Return on Capital (ROIC) | -41.80% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +62.96% in the last 52 weeks. The beta is 3.39, so PharmaTher Holdings's price volatility has been higher than the market average.
Beta (5Y) | 3.39 |
52-Week Price Change | +62.96% |
50-Day Moving Average | 0.24 |
200-Day Moving Average | 0.24 |
Relative Strength Index (RSI) | 55.07 |
Average Volume (20 Days) | 118,575 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -2.02M |
Pretax Income | -2.16M |
Net Income | -2.16M |
EBITDA | -2.02M |
EBIT | -2.02M |
Earnings Per Share (EPS) | -0.02 |
Balance Sheet
Cash & Cash Equivalents | 1.90M |
Total Debt | n/a |
Net Cash | 1.90M |
Net Cash Per Share | 0.02 |
Equity (Book Value) | 1.96M |
Book Value Per Share | 0.02 |
Working Capital | 1.71M |
Cash Flow
Operating Cash Flow | -2.50M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
PharmaTher Holdings does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.16% |
Shareholder Yield | -0.16% |
Earnings Yield | -9.99% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |